ChemicalBook >?? ???? >[1,1'-Biphenyl]-4-carboxylicacid, hexahydro-2-oxo-4-(3-oxo-4-phenoxy-1-butenyl)-2H-cyclopenta[b]furan-5-yl ester, [3aR-[3aα,4α(E),5β,6aα]]- (9CI)
[1,1'-Biphenyl]-4-carboxylicacid, hexahydro-2-oxo-4-(3-oxo-4-phenoxy-1-butenyl)-2H-cyclopenta[b]furan-5-yl ester, [3aR-[3aα,4α(E),5β,6aα]]- (9CI)
|
|
[1,1'-Biphenyl]-4-carboxylicacid, hexahydro-2-oxo-4-(3-oxo-4-phenoxy-1-butenyl)-2H-cyclopenta[b]furan-5-yl ester, [3aR-[3aα,4α(E),5β,6aα]]- (9CI) ??
- ?? ?
- 699.0±55.0 °C(Predicted)
- ??
- 1.30±0.1 g/cm3(Predicted)
??
[1,1'-Biphenyl]-4-carboxylicacid, hexahydro-2-oxo-4-(3-oxo-4-phenoxy-1-butenyl)-2H-cyclopenta[b]furan-5-yl ester, [3aR-[3aα,4α(E),5β,6aα]]- (9CI) C??? ??, ??, ??
??
(3aR,4R,5R,6aS)-2-Oxo-4-((E)-3-oxo-4-phenoxybut-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-5-yl [1,1''-biphenyl]-4-carboxylate is an intermediate used in the synthesis of N-(Methanesulfonyl)-16-phenoxyprostaglandin Carboxamides, a tissue-selective uterine stimulant.[1,1'-Biphenyl]-4-carboxylicacid, hexahydro-2-oxo-4-(3-oxo-4-phenoxy-1-butenyl)-2H-cyclopenta[b]furan-5-yl ester, [3aR-[3aα,4α(E),5β,6aα]]- (9CI) ?? ?? ? ???
???
?? ??
[1,1'-Biphenyl]-4-carboxylicacid, hexahydro-2-oxo-4-(3-oxo-4-phenoxy-1-butenyl)-2H-cyclopenta[b]furan-5-yl ester, [3aR-[3aα,4α(E),5β,6aα]]- (9CI) ?? ??
???( 6)?? ??
??? | ?? | ??? | ?? | ?? ? | ?? |
---|---|---|---|---|---|
CR Corporation Limited | +8613062833949 |
fred.wen@crcorporation.cn | China | 8647 | 58 |
Chengdu Apis Pharmaceutical Technology Co.,Ltd | 13568817957 |
dudes@163.com | China | 300 | 58 |
Zhengzhou Kangshan Biological Co., Ltd. | +86-0371-55023472 +86-13663848272 |
2584787837@qq.com | China | 244 | 58 |
Hangzhou Yuprun Biological Technology Co., Ltd | 13216153979 |
herminhuang@yuprun.com | China | 335 | 58 |
Nanjing Xinsi Chemical Co., Ltd. | 18805263762 |
nanjingxinsi@163.com | China | 434 | 58 |
Henan Mengtai Pharmaceutical Technology Co., Ltd | 17634534467 17634534467 |
1959525201@qq.com | China | 5251 | 58 |